10-Q quarterly report · filed Oct 23, 2026

CME Group (CME) Q3 2026 10-Q Quarterly Report

Short answer

CME Group (CME) filed its Q3 2026 10-Q quarterly report on Oct 23, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.7B (up 13.0% year over year) with net income of $1.0B.

Q3 2026 key financials · XBRL

Revenue
$1.7B
+13.0% YoY · +1.8% QoQ
Net income
$1.0B
+15.6% YoY · +0.9% QoQ
Operating margin
65.7%
EPS (diluted)
$2.90
+16.5% YoY · +0.7% QoQ

Source: XBRL data from the CME Group (CME) Q3 2026 10-Q on SEC EDGAR. USD.

CME Group Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $1,737.3M, up from $1,537.6M YoY, with clearing and transaction fees $1,378.1M vs $1,227.9M
  • Operating margin 65.7% vs 63.3% YoY, net income $1,036.9M vs $908.0M
  • Strongest product line: interest rates, average daily volume 15,121 vs 13,378 thousand
  • Weakest product line: cryptocurrency, contract volumes decreased versus the third quarter of 2025
  • Operating cash flow $3,292.9M vs $3,143.2M, cash $2.2B vs $4.4B at December 31, 2025, share repurchase authorization remaining $1.0B

Risk Factors

  • No material changes to risk factors since the December 31, 2025 Form 10-K
  • Carried-forward risks remain the principal regulatory, operational, market and financial exposures identified in the 10-K

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other CME Group quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.